A share price of CVS Health Corp [CVS] is currently trading at $73.15, up 1.40%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CVS shares have gain 2.59% over the last week, with a monthly amount glided 17.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on August 18, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $79 for it. Previously, Robert W. Baird upgraded its rating to Outperform on August 14, 2025, and kept the price target unchanged to $82. On February 13, 2025, upgrade upgraded it’s rating to Outperform and revised its price target to $75 on the stock. Cantor Fitzgerald upgraded its rating to a Overweight. Edward Jones upgraded its rating to a Buy. Deutsche Bank upgraded its rating to Buy for this stock on December 03, 2024, but kept the price target unchanged to $66. In a note dated November 18, 2024, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $60 to $66.
CVS Health Corp experienced fluctuations in its stock price throughout the past year between $43.56 and $72.51. Currently, Wall Street analysts expect the stock to reach $80 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $73.15 at the most recent close of the market. An investor can expect a potential return of 9.36% based on the average CVS price forecast.
Analyzing the CVS fundamentals
Trailing Twelve Months sales for CVS Health Corp [NYSE:CVS] were 386.46B which represents 8.34% growth. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.06 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 72.46 points at the first support level, and at 71.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 73.53, and for the 2nd resistance point, it is at 73.92.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CVS Health Corp [NYSE:CVS] is 0.80. In addition, the Quick Ratio stands at 0.62 and the Cash Ratio stands at 0.13. Considering the valuation of this stock, the price to sales ratio is 0.24, the price to book ratio is 1.20 and price to earnings (TTM) ratio is 20.41.
Transactions by insiders
Recent insider trading involved Finucane Anne A., Director, that happened on Aug 20 ’25 when 7500.0 shares were sold. Director, Finucane Anne A. completed a deal on Aug 20 ’25 to buy 7500.0 shares. Meanwhile, Director SANSONE GUY P bought 1570.0 shares on Jun 05 ’25.
